Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38907 |
FTISADTSK
|
||
FTISADTSK is an endogenous stable signature peptide derived from Trastuzumab, which can be accurately assessed using selected reaction monitoring (SRM). | |||
T38023 |
FTISADTSK acetate
|
||
FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1]. |